nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—Telangiectasia—Fluorouracil—urinary bladder cancer	0.07	0.0869	CcSEcCtD
Prednicarbate—NR3C1—urine—urinary bladder cancer	0.0472	0.317	CbGeAlD
Prednicarbate—Allergic contact dermatitis—Fluorouracil—urinary bladder cancer	0.0472	0.0586	CcSEcCtD
Prednicarbate—Leukoderma—Thiotepa—urinary bladder cancer	0.0469	0.0582	CcSEcCtD
Prednicarbate—Telangiectasia—Methotrexate—urinary bladder cancer	0.0364	0.0452	CcSEcCtD
Prednicarbate—Secondary infection—Epirubicin—urinary bladder cancer	0.0273	0.0339	CcSEcCtD
Prednicarbate—Eruption—Gemcitabine—urinary bladder cancer	0.0273	0.0338	CcSEcCtD
Prednicarbate—Secondary infection—Doxorubicin—urinary bladder cancer	0.0253	0.0314	CcSEcCtD
Prednicarbate—Leukoderma—Methotrexate—urinary bladder cancer	0.0202	0.025	CcSEcCtD
Prednicarbate—Dermatitis contact—Thiotepa—urinary bladder cancer	0.0197	0.0245	CcSEcCtD
Prednicarbate—Infection—Carboplatin—urinary bladder cancer	0.0189	0.0234	CcSEcCtD
Prednicarbate—Leukoderma—Epirubicin—urinary bladder cancer	0.0189	0.0234	CcSEcCtD
Prednicarbate—Leukoderma—Doxorubicin—urinary bladder cancer	0.0175	0.0217	CcSEcCtD
Prednicarbate—NR3C1—prostate gland—urinary bladder cancer	0.0169	0.114	CbGeAlD
Prednicarbate—Dermatitis contact—Fluorouracil—urinary bladder cancer	0.0163	0.0202	CcSEcCtD
Prednicarbate—Pain—Carboplatin—urinary bladder cancer	0.0163	0.0202	CcSEcCtD
Prednicarbate—Pruritus—Valrubicin—urinary bladder cancer	0.0145	0.018	CcSEcCtD
Prednicarbate—NR3C1—seminal vesicle—urinary bladder cancer	0.0143	0.0963	CbGeAlD
Prednicarbate—Oedema—Mitomycin—urinary bladder cancer	0.0141	0.0176	CcSEcCtD
Prednicarbate—Eruption—Methotrexate—urinary bladder cancer	0.0139	0.0173	CcSEcCtD
Prednicarbate—Folliculitis—Methotrexate—urinary bladder cancer	0.0136	0.0169	CcSEcCtD
Prednicarbate—Eruption—Epirubicin—urinary bladder cancer	0.013	0.0162	CcSEcCtD
Prednicarbate—Rash—Valrubicin—urinary bladder cancer	0.0129	0.0161	CcSEcCtD
Prednicarbate—Dermatitis—Valrubicin—urinary bladder cancer	0.0129	0.0161	CcSEcCtD
Prednicarbate—Folliculitis—Epirubicin—urinary bladder cancer	0.0128	0.0159	CcSEcCtD
Prednicarbate—NR3C1—epithelium—urinary bladder cancer	0.0124	0.0837	CbGeAlD
Prednicarbate—Pain—Mitomycin—urinary bladder cancer	0.0121	0.015	CcSEcCtD
Prednicarbate—Eruption—Doxorubicin—urinary bladder cancer	0.0121	0.015	CcSEcCtD
Prednicarbate—NR3C1—smooth muscle tissue—urinary bladder cancer	0.012	0.0806	CbGeAlD
Prednicarbate—Folliculitis—Doxorubicin—urinary bladder cancer	0.0118	0.0147	CcSEcCtD
Prednicarbate—NR3C1—renal system—urinary bladder cancer	0.0115	0.0776	CbGeAlD
Prednicarbate—NR3C1—urethra—urinary bladder cancer	0.0113	0.0762	CbGeAlD
Prednicarbate—NR3C1—female reproductive system—urinary bladder cancer	0.00925	0.0622	CbGeAlD
Prednicarbate—Rash—Mitomycin—urinary bladder cancer	0.00892	0.0111	CcSEcCtD
Prednicarbate—Dermatitis—Mitomycin—urinary bladder cancer	0.00891	0.0111	CcSEcCtD
Prednicarbate—NR3C1—vagina—urinary bladder cancer	0.00836	0.0562	CbGeAlD
Prednicarbate—Dermatitis contact—Epirubicin—urinary bladder cancer	0.00793	0.00985	CcSEcCtD
Prednicarbate—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.00734	0.00911	CcSEcCtD
Prednicarbate—Infection—Thiotepa—urinary bladder cancer	0.00706	0.00877	CcSEcCtD
Prednicarbate—Paraesthesia—Thiotepa—urinary bladder cancer	0.00639	0.00793	CcSEcCtD
Prednicarbate—Pain—Thiotepa—urinary bladder cancer	0.00608	0.00755	CcSEcCtD
Prednicarbate—Oedema—Gemcitabine—urinary bladder cancer	0.00598	0.00743	CcSEcCtD
Prednicarbate—Infection—Gemcitabine—urinary bladder cancer	0.00594	0.00738	CcSEcCtD
Prednicarbate—Oedema—Fluorouracil—urinary bladder cancer	0.00588	0.0073	CcSEcCtD
Prednicarbate—Infection—Fluorouracil—urinary bladder cancer	0.00584	0.00726	CcSEcCtD
Prednicarbate—Urticaria—Thiotepa—urinary bladder cancer	0.00565	0.00701	CcSEcCtD
Prednicarbate—Oedema—Cisplatin—urinary bladder cancer	0.00558	0.00692	CcSEcCtD
Prednicarbate—Infection—Cisplatin—urinary bladder cancer	0.00554	0.00688	CcSEcCtD
Prednicarbate—NR3C1—lymph node—urinary bladder cancer	0.00541	0.0364	CbGeAlD
Prednicarbate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00537	0.00667	CcSEcCtD
Prednicarbate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00528	0.00656	CcSEcCtD
Prednicarbate—Pain—Gemcitabine—urinary bladder cancer	0.00512	0.00635	CcSEcCtD
Prednicarbate—Infection—Etoposide—urinary bladder cancer	0.00507	0.0063	CcSEcCtD
Prednicarbate—Pruritus—Thiotepa—urinary bladder cancer	0.00503	0.00625	CcSEcCtD
Prednicarbate—Pain—Fluorouracil—urinary bladder cancer	0.00503	0.00624	CcSEcCtD
Prednicarbate—Paraesthesia—Cisplatin—urinary bladder cancer	0.00501	0.00622	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—BPTF—urinary bladder cancer	0.00485	0.113	CbGpPWpGaD
Prednicarbate—Pain—Cisplatin—urinary bladder cancer	0.00477	0.00592	CcSEcCtD
Prednicarbate—Urticaria—Fluorouracil—urinary bladder cancer	0.00467	0.0058	CcSEcCtD
Prednicarbate—Paraesthesia—Etoposide—urinary bladder cancer	0.00459	0.0057	CcSEcCtD
Prednicarbate—Rash—Thiotepa—urinary bladder cancer	0.00448	0.00557	CcSEcCtD
Prednicarbate—Dermatitis—Thiotepa—urinary bladder cancer	0.00448	0.00556	CcSEcCtD
Prednicarbate—Pain—Etoposide—urinary bladder cancer	0.00437	0.00542	CcSEcCtD
Prednicarbate—Pruritus—Gemcitabine—urinary bladder cancer	0.00423	0.00525	CcSEcCtD
Prednicarbate—Pruritus—Fluorouracil—urinary bladder cancer	0.00416	0.00517	CcSEcCtD
Prednicarbate—Urticaria—Etoposide—urinary bladder cancer	0.00406	0.00504	CcSEcCtD
Prednicarbate—Rash—Gemcitabine—urinary bladder cancer	0.00377	0.00468	CcSEcCtD
Prednicarbate—Dermatitis—Gemcitabine—urinary bladder cancer	0.00377	0.00468	CcSEcCtD
Prednicarbate—Rash—Fluorouracil—urinary bladder cancer	0.00371	0.0046	CcSEcCtD
Prednicarbate—Dermatitis—Fluorouracil—urinary bladder cancer	0.00371	0.0046	CcSEcCtD
Prednicarbate—Pruritus—Etoposide—urinary bladder cancer	0.00361	0.00449	CcSEcCtD
Prednicarbate—Rash—Cisplatin—urinary bladder cancer	0.00352	0.00437	CcSEcCtD
Prednicarbate—Dermatitis—Cisplatin—urinary bladder cancer	0.00351	0.00436	CcSEcCtD
Prednicarbate—Rash—Etoposide—urinary bladder cancer	0.00322	0.004	CcSEcCtD
Prednicarbate—Dermatitis—Etoposide—urinary bladder cancer	0.00322	0.004	CcSEcCtD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.00321	0.0745	CbGpPWpGaD
Prednicarbate—Infection—Methotrexate—urinary bladder cancer	0.00304	0.00377	CcSEcCtD
Prednicarbate—Oedema—Epirubicin—urinary bladder cancer	0.00286	0.00356	CcSEcCtD
Prednicarbate—Infection—Epirubicin—urinary bladder cancer	0.00284	0.00353	CcSEcCtD
Prednicarbate—Paraesthesia—Methotrexate—urinary bladder cancer	0.00275	0.00341	CcSEcCtD
Prednicarbate—Oedema—Doxorubicin—urinary bladder cancer	0.00265	0.00329	CcSEcCtD
Prednicarbate—Infection—Doxorubicin—urinary bladder cancer	0.00263	0.00327	CcSEcCtD
Prednicarbate—Pain—Methotrexate—urinary bladder cancer	0.00262	0.00325	CcSEcCtD
Prednicarbate—Paraesthesia—Epirubicin—urinary bladder cancer	0.00257	0.00319	CcSEcCtD
Prednicarbate—Pain—Epirubicin—urinary bladder cancer	0.00245	0.00304	CcSEcCtD
Prednicarbate—Urticaria—Methotrexate—urinary bladder cancer	0.00243	0.00302	CcSEcCtD
Prednicarbate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00238	0.00295	CcSEcCtD
Prednicarbate—Urticaria—Epirubicin—urinary bladder cancer	0.00227	0.00282	CcSEcCtD
Prednicarbate—Pain—Doxorubicin—urinary bladder cancer	0.00227	0.00281	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—KRT5—urinary bladder cancer	0.00219	0.051	CbGpPWpGaD
Prednicarbate—Pruritus—Methotrexate—urinary bladder cancer	0.00216	0.00269	CcSEcCtD
Prednicarbate—Urticaria—Doxorubicin—urinary bladder cancer	0.0021	0.00261	CcSEcCtD
Prednicarbate—Pruritus—Epirubicin—urinary bladder cancer	0.00203	0.00252	CcSEcCtD
Prednicarbate—Rash—Methotrexate—urinary bladder cancer	0.00193	0.0024	CcSEcCtD
Prednicarbate—Dermatitis—Methotrexate—urinary bladder cancer	0.00193	0.00239	CcSEcCtD
Prednicarbate—Pruritus—Doxorubicin—urinary bladder cancer	0.00187	0.00233	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.00185	0.043	CbGpPWpGaD
Prednicarbate—Rash—Epirubicin—urinary bladder cancer	0.00181	0.00224	CcSEcCtD
Prednicarbate—Dermatitis—Epirubicin—urinary bladder cancer	0.0018	0.00224	CcSEcCtD
Prednicarbate—Rash—Doxorubicin—urinary bladder cancer	0.00167	0.00207	CcSEcCtD
Prednicarbate—Dermatitis—Doxorubicin—urinary bladder cancer	0.00167	0.00207	CcSEcCtD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00157	0.0365	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—ESR2—urinary bladder cancer	0.00156	0.0361	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.00133	0.031	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00123	0.0286	CbGpPWpGaD
Prednicarbate—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.00123	0.44	CrCbGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—urinary bladder cancer	0.00123	0.0285	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—urinary bladder cancer	0.000943	0.0219	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—ESR1—urinary bladder cancer	0.000943	0.0219	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—NCOR1—urinary bladder cancer	0.000894	0.0208	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—PPARG—urinary bladder cancer	0.000861	0.02	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—urinary bladder cancer	0.000845	0.0196	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.000746	0.0173	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—TNF—urinary bladder cancer	0.000708	0.0164	CbGpPWpGaD
Prednicarbate—Triamcinolone—PTGS2—urinary bladder cancer	0.00068	0.244	CrCbGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00068	0.0158	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000656	0.0152	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.000634	0.0147	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—CREBBP—urinary bladder cancer	0.000615	0.0143	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000615	0.0143	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.000579	0.0134	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.000575	0.0134	CbGpPWpGaD
Prednicarbate—Betamethasone—PTGS2—urinary bladder cancer	0.000557	0.2	CrCbGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000517	0.012	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.000515	0.012	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000503	0.0117	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000451	0.0105	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.000449	0.0104	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.000447	0.0104	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000444	0.0103	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000432	0.01	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.00042	0.00975	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.000419	0.00973	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000403	0.00936	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.000402	0.00935	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000385	0.00894	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000375	0.00872	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000364	0.00846	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000362	0.00842	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000355	0.00825	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000345	0.00803	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000339	0.00788	CbGpPWpGaD
Prednicarbate—Dexamethasone—PTGS2—urinary bladder cancer	0.000324	0.116	CrCbGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000323	0.0075	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.000322	0.00748	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.00032	0.00743	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.000308	0.00715	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000307	0.00714	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000305	0.00709	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000304	0.00707	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000301	0.00699	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000268	0.00622	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000267	0.00621	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000247	0.00574	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	0.000221	0.00514	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000218	0.00506	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000212	0.00493	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000212	0.00493	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000182	0.00423	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—TNF—urinary bladder cancer	0.000171	0.00397	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000164	0.00381	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000148	0.00343	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000129	0.00299	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000117	0.00273	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	0.000117	0.00273	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000113	0.00262	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ESR2—urinary bladder cancer	0.000102	0.00238	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	7.89e-05	0.00183	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	7.42e-05	0.00172	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	6.7e-05	0.00156	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ESR1—urinary bladder cancer	6.2e-05	0.00144	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—PPARG—urinary bladder cancer	5.66e-05	0.00131	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	5.43e-05	0.00126	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MYC—urinary bladder cancer	3.23e-05	0.000749	CbGpPWpGaD
